Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation - Nakamura, Masato; Iijima, Raisuke; Ako, Junya; Shinke, Toshiro; Okada, Hisayuki; Ito, Yoshiaki; Ando, Kenji; Tanaka, Hiroyuki; Takiuchi, Shin; Nishida, Yasunori; Kawaguchi, Katsuhiro; Kadotani, Makoto; et al. (JACC. Cardiovascular interventions, 2017)
Keywords: Absorbable Implants; Acute Coronary Syndrome - complications; Acute Coronary Syndrome - diagnosis; Acute Coronary Syndrome - mortality; Acute Coronary Syndrome - therapy; Aged; Aspirin - administration & dosage; Aspirin - adverse effects; biodegradable polymer; Cardiovascular; Clopidogrel; Coronary Artery Disease - complications; Coronary Artery Disease - diagnosis; Coronary Artery Disease - mortality; Coronary Artery Disease - therapy; Drug Administration Schedule; Drug Therapy, Combination; drug-eluting stent(s); Drug-Eluting Stents; dual antiplatelet therapy; Female; Hemorrhage - chemically induced; Humans; Intention to Treat Analysis; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction - etiology; Myocardial Infarction - mortality; net adverse clinical and cerebrovascular event(s); Percutaneous Coronary Intervention - adverse effects; Percutaneous Coronary Intervention - instrumentation; Percutaneous Coronary Intervention - mortality; Platelet Aggregation Inhibitors - administration & dosage; Platelet Aggregation Inhibitors - adverse effects; Polymers - chemistry; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Factors; stent thrombosis; Stroke - etiology; Stroke - mortality; Ticlopidine - administration & dosage; Ticlopidine - adverse effects; Ticlopidine - analogs & derivatives; Time Factors; Treatment Outcome; RCT; biodegradable polymer; CI; net adverse clinical and cerebrovascular event(s); ITT; HR; BARC; drug-eluting stent(s); dual antiplatelet therapy; DES; stent thrombosis; PCI; PH; NACCE; MI; DAPT; confidential interval; myocardial infarction; Bleeding Academic Research Consortium; randomized controlled trial; percutaneous coronary intervention; intention to treat; hazard ratio; proportional hazard